A detailed history of Tributary Capital Management, LLC transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Tributary Capital Management, LLC holds 1,310 shares of TMO stock, worth $692,963. This represents 0.06% of its overall portfolio holdings.

Number of Shares
1,310
Previous 1,360 3.68%
Holding current value
$692,963
Previous $752,000 7.71%
% of portfolio
0.06%
Previous 0.06%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$531.86 - $624.21 $26,593 - $31,210
-50 Reduced 3.68%
1,310 $810,000
Q2 2024

Jul 24, 2024

SELL
$541.52 - $599.02 $29,783 - $32,946
-55 Reduced 3.89%
1,360 $752,000
Q1 2024

Apr 18, 2024

SELL
$528.82 - $599.43 $15,864 - $17,982
-30 Reduced 2.08%
1,415 $822,000
Q4 2023

Jan 16, 2024

SELL
$431.41 - $532.94 $10,785 - $13,323
-25 Reduced 1.7%
1,445 $766,000
Q3 2023

Oct 11, 2023

SELL
$498.29 - $574.41 $9,965 - $11,488
-20 Reduced 1.34%
1,470 $744,000
Q2 2023

Jul 17, 2023

SELL
$508.46 - $591.13 $7,626 - $8,866
-15 Reduced 1.0%
1,490 $777,000
Q1 2023

Apr 26, 2023

BUY
$535.0 - $604.82 $26,750 - $30,241
50 Added 3.44%
1,505 $867,000
Q4 2022

Jan 27, 2023

SELL
$484.71 - $571.37 $12,117 - $14,284
-25 Reduced 1.69%
1,455 $801,000
Q3 2022

Oct 11, 2022

SELL
$507.19 - $604.49 $7,607 - $9,067
-15 Reduced 1.0%
1,480 $751,000
Q2 2022

Jul 19, 2022

SELL
$500.9 - $612.21 $22,540 - $27,549
-45 Reduced 2.92%
1,495 $812,000
Q1 2022

Apr 22, 2022

SELL
$524.0 - $644.92 $20,960 - $25,796
-40 Reduced 2.53%
1,540 $910,000
Q4 2021

Jan 06, 2022

SELL
$569.0 - $667.24 $36,985 - $43,370
-65 Reduced 3.95%
1,580 $1.05 Million
Q3 2021

Oct 14, 2021

SELL
$509.53 - $609.78 $17,833 - $21,342
-35 Reduced 2.08%
1,645 $940,000
Q2 2021

Jul 15, 2021

SELL
$441.0 - $508.24 $13,230 - $15,247
-30 Reduced 1.75%
1,680 $848,000
Q1 2021

Apr 20, 2021

BUY
$439.85 - $518.83 $90,169 - $106,360
205 Added 13.62%
1,710 $780,000
Q4 2020

Jan 19, 2021

SELL
$435.06 - $527.66 $152,271 - $184,681
-350 Reduced 18.87%
1,505 $701,000
Q3 2020

Oct 13, 2020

SELL
$359.77 - $441.52 $34,178 - $41,944
-95 Reduced 4.87%
1,855 $819,000
Q2 2020

Jul 20, 2020

SELL
$275.2 - $362.34 $24,768 - $32,610
-90 Reduced 4.41%
1,950 $707,000
Q1 2020

Apr 14, 2020

SELL
$255.3 - $340.05 $12,765 - $17,002
-50 Reduced 2.39%
2,040 $579,000
Q4 2019

Jan 16, 2020

SELL
$271.93 - $328.04 $108,772 - $131,216
-400 Reduced 16.06%
2,090 $679,000
Q3 2019

Oct 15, 2019

SELL
$268.46 - $305.43 $9,396 - $10,690
-35 Reduced 1.39%
2,490 $725,000
Q2 2019

Jul 11, 2019

SELL
$257.51 - $295.55 $199,570 - $229,051
-775 Reduced 23.48%
2,525 $742,000
Q3 2018

Oct 16, 2018

SELL
$205.57 - $244.32 $10,278 - $12,216
-50 Reduced 1.49%
3,300 $805,000
Q2 2018

Jul 25, 2018

SELL
$203.14 - $219.53 $50,785 - $54,882
-250 Reduced 6.94%
3,350 $694,000
Q1 2018

Apr 19, 2018

SELL
$192.98 - $224.11 $77,192 - $89,644
-400 Reduced 10.0%
3,600 $743,000
Q4 2017

Jan 25, 2018

SELL
$182.03 - $200.37 $36,406 - $40,074
-200 Reduced 4.76%
4,000 $760,000
Q3 2017

Oct 19, 2017

BUY
$171.74 - $194.04 $721,308 - $814,968
4,200
4,200 $795,000

Others Institutions Holding TMO

About THERMO FISHER SCIENTIFIC INC.


  • Ticker TMO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 391,788,992
  • Market Cap $207B
  • Description
  • Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...
More about TMO
Track This Portfolio

Track Tributary Capital Management, LLC Portfolio

Follow Tributary Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tributary Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tributary Capital Management, LLC with notifications on news.